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Background: Contrast-enhanced magnetic resonance angiography (CE-MRA) is a proven diagnostic tool for the
evaluation of carotid stenosis; however, its utility in planning carotid artery stenting (CAS) has not been addressed. This
study assessed the accuracy of three-dimensional CE-MRA as a noninvasive screening tool, compared with digital
subtraction angiography (DSA), for evaluating carotid and arch morphology before CAS.
Methods: In a series of 96 CAS procedures during a 2-year period, CE-MRAs and DSAs with complete visualization from
the aortic arch to the intracranial circulation were obtained before CAS in 60 patients. Four additional patients, initially
considered potential candidates for CAS, were also evaluated with CE-MRA and DSA. The two-by-two table method,
receiver operating characteristic curve, and Bland-Altman analyses were used to characterize the ability of CE-MRA to
discriminate carotid and arch anatomy, suitability for CAS, and degree of carotid stenosis.
Results: The sensitivity and specificity of CE-MRA were, respectively, 100% and 100% to determine CAS suitability, 87%
and 100% to define aortic arch type, 93% and 100% to determine severe carotid tortuosity, and 75% and 98% to detect
ulcerated plaques. CE-MRA had 87% sensitivity and 100% specificity for the detection of carotid stenosis >80%. The
accuracy of CE MRA to determine optimal imaging angles and stent and embolic protection device sizes was >90%. The
operative technique for CAS was altered because of the findings of preoperative CE-MRA in 22 procedures (38%). The
most frequent change in the operative plan was the use of the telescoping technique in 11 cases (18%). CAS was aborted
in four patients (5%) due to unfavorable anatomy identified on CE-MRA, including prohibitive internal carotid artery
tortuosity (n  1), long string sign of the internal carotid artery (n  2), and concomitant intracranial disease (n  1).
Among patients considered suitable for CAS by CE-MRA, technical success was 100%, and the 30-day stroke/death rate
was 1.6%.
Conclusions: Contrast-enhanced magnetic resonance angiography of the arch and carotid arteries is accurate in determin-
ing suitability for CAS and may alter the operative technique. Certain anatomic contraindications for CAS may be
detected without DSA. Although CE-MRA is less accurate to estimate the degree of stenosis, it can accurately predict
imaging angles, and stent and embolic protection device size, whichmay facilitate safe and expeditious CAS. (J Vasc Surg
2007;46:257-64.)Digital subtraction angiography (DSA) is still consid-
ered the gold standard for the evaluation of atherosclerotic
lesions of the carotid arteries. This procedure is, however,
invasive and carries a small but definite risk of complica-
tions, including cerebrovascular thromboembolicevents.1
Noninvasive methods such as magnetic resonance angiog-
raphy (MRA), computed tomography angiography (CTA),
and duplex ultrasound imaging (DUI) have been evaluated
as possible alternatives to DSA.
Overall, previous observational studies comparing DSA
and contrast-enhanced MRA (CE-MRA) have consistently
revealed a strong correlation of the degree of carotid ste-
nosis estimated with these two diagnostic modalities, de-
From the Division of Vascular and Endovascular Surgery, Department of
Surgery, University of Texas Southwestern Medical Center and Dallas
Veterans Affairs Medical Center.
Competition of interest: none.
Presented at the Thirty-first AnnualMeeting of the Southern Association for
Vascular Surgery, Rio Grande, Puerto Rico, Jan 17-20, 2007.
Correspondence: Carlos H. Timaran, MD, University of Texas Southwest-
ern Medical Center, 5909 Harry Hines Blvd, Dallas, TX 75390-9157
(e-mail: carlos.timaran@utsouthwestern.edu).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2007.03.051spite an occasional tendency toward overestimation re-
ported with CE-MRA.2-6 Although CE-MRA has been
widely used to corroborate the degree of carotid stenosis
determined with DU before performing carotid endarter-
ectomy (CEA), to our knowledge, its utility in planning
carotid angioplasty and stenting (CAS) has not been as-
sessed.
Carotid stenting with cerebral embolic protection is
currently performed primarily for the treatment of carotid
stenosis in high-risk surgical patients; that is, those with
significant comorbidities or a hostile neck from previous
surgical procedures or radiation.7-10 The role of CAS for
the treatment of carotid stenosis among low-risk patients
has not been defined, and although recent randomized
clinical trials have reported inferior outcomes after
CAS,11,12 its usefulness will only be established once the
results of larger and rigorous clinical trials become avail-
able.13,14
Because the learning curve for CAS is prolonged and
challenging, patient selection is critical to minimize adverse
outcomes.15,16 Unfavorable anatomic variations are the
main limiting factor during CAS.17,18 As a consequence, it
has been suggested that during the early experience with
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anticipate the difficulty of the case and to select the appro-
priate techniques and tools.19 Alternative preoperative im-
aging studies, such as CE-MRA, which is capable of assess-
ing from the aortic arch to the intracranial circulation,
could be used in preparation for CAS.
This study was designed to assess the accuracy of three-
dimensional (3D) CE-MRA as a noninvasive screening
tool, compared with DSA, for evaluating carotid and arch
morphology of patients with carotid stenosis being consid-
ered for CAS.
METHODS
During a 2-year period from September 2004 to Sep-
tember 2006, 96 CAS procedures were performed in 90
men and two women at high risk or with contraindications
for CEA.17,20 Indications included moderate (50%)
symptomatic carotid stenosis or severe (80%) asymptom-
atic carotid stenosis determined with DUI. CE-MRA and
DSA were obtained in 82 patients before CAS. In 60
patients, CE-MRA imaged the aortic arch, the complete
course of the extracranial carotid arteries, and the intracra-
nial circulation. Four additional patients, initially consid-
ered potential candidates for CAS, were also evaluated with
CE-MRA and DSA. Data from this group of 64 patients, in
whom aortic arch, cervical, and intracranial carotid CE-
MRA and DSA was obtained for preoperative work-up
before CAS, were prospectively entered into a database
designed for this anatomic study, which was approved by
the local Institutional Review Board.
CE-MRAwas performed with an Avanto 1.5-Tmagnet
machine (Siemens, Bala Cynwyd, Pa) using a 3D sub-
tracted fast gradient-echo sequence and turbo fast low-
angle shot sequence (4/1.6 repetition time msec/echo
time msec; flip angle, 20°; matrix, 120-128 128-256). A
total dose of 20 mL of gadolinium-based contrast material
(ProHance; Bracco Diagnostics, Princeton, NJ) was in-
jected into an antecubital vein. A bolus test preceded
imaging acquisition with scan delay automatically calcu-
lated to optimize aortic arch imaging.
The MRA studies were processed with a maximum-
intensity-projection algorithm to display 3D projections of
each carotid bifurcation. For the 3D CE-MRA, the maxi-
mum-intensity-projection algorithm was used after sub-
tracting the sequence that showed the best arterial en-
hancement. MRI analysis software with magnification and
precise cursor placement was used for diameter measure-
ments. CE-MRA images were further evaluated using 3D
reconstruction on a Vitrea workstation (Vital Images, Ply-
mouth, Minn) to determine carotid tortuosity and optimal
angles of projections and views to image the aortic arch,
great vessels, intracranial circulation, and target lesions.
Baseline and postoperative angiograms and all CAS
procedures were performedwith anOEC/GEModel 9800
mobile C-arm (OEC, Salt Lake City, Utah) or fixed angio-
graphic units (AXIOM Artis dTA, Siemens, Malvern, Pa or
Allura Xper FD10, Philips, Bothell, Wash). Baseline DSAstudies were performed concurrently with the CAS proce-
dure.
Angiographic projections that demonstrated the most
severe degree of stenosis were selected. Measurements of
angiographic carotid stenosis (percentage by diameter) in
both CE-MRA and DSA images were performed according
to North American Symptomatic Carotid Endarterectomy
(NASCET) methodology.21 A signal void on MRA was
assumed to represent a 70% stenosis.22
CE-MRA and DSA images were further evaluated for
the presence of plaque ulcers, occlusion, and other signifi-
cant stenoses from the aortic arch to the circle ofWillis. The
presence of a plaque ulcer was confirmed when an ulcer
niche was clearly seen (ie, a crater penetrating into a ste-
notic plaque).
Aortic arch morphology and elongation (types I, II,
and III),23 and carotid lesion length and carotid tortuosity
were also evaluated. Common carotid artery (CCA) and
internal carotid artery (ICA) tortuosity was graded accord-
ing to the vascular angulation from the proximal center line
flow (absent, 0°; mild,30°; moderate, 30° to 60°; severe,
60°).24,25
CE-MRA images were further used to estimate imag-
ing angles, target lesion suitability for CAS, changes in CAS
technique, and stent and embolic protection device (EPD)
sizes. Suitability for CAS was determined according to
aortic arch morphology, ICA/CCA tortuosity, and target
lesion characteristics. CAS suitability was defined as the
expectation of delivering an EPD and stent to the target site
according to the clinicians’ experience and the current
practice with CAS systems commercially available in the
United States.
Procedural details and CAS protocols at our institution
have been described in detail.19 Briefly, the sequential
over-the-wire technique was primarily used. Several types
and models of cerebral protection device were used to
prevent distal embolization: Abbott Accunet filter (ACCU-
LINK System, Abbott Vascular, Santa Clara, Calif), Filter-
Wire EZ system (Boston Scientific, Natick, Mass), and
Angioguard Filter (Cordis, Warren, NJ). Three self-ex-
panding stents were used: Acculink carotid stent (Acculink
System, Abbott Vascular, Santa Clara, Calif), Carotid Wall-
stent (Boston Scientific Corp, Natick, Mass), and PRE-
CISE carotid stent (Cordis, Warren, NJ).
Descriptive statistics for categoric variables are pre-
sented as relative frequencies (percentages). Continuous
variables were expressed as medians and interquartile
ranges (IQR). For the purpose of this study, matched and
paired carotid lesion and vessel-based evaluations and com-
parisons of CAS suitability and aortic arch and carotid
morphologic measures as assessed in CE-MRA and DSA
images were performed. Spearman rank correlation coeffi-
cients (Spearman ) with 95% confidence intervals (CI) of
angiographic carotid stenosis and vessel size measurements
were calculated. The two  two table method, receiver
operating characteristic (ROC) curve, and Bland-Altman
analyses were further used to characterize the ability of
CE-MRA to discriminate carotid and arch anatomy, suit-
binom
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the reference standard. Computation of binomial propor-
tion and exact confidence limits for one-way tables was
performed using the F distribution method. Findings were
considered statistically significant if the resulting value P
was .05. The SAS 9.1 (SAS Institute, Cary, NC) and
MedCalc 8.1.0.0 (MedCalc Software, Mariakerke, Bel-
gium) software programs were used for data analyses.
RESULTS
Aortic arch, cervical, and intracranial carotid CE-MRA
and DSA imaging data were available for comparison in 60
CAS procedures (59 men and 1 woman) and four addi-
tional high-risk men that were ultimately considered not
suitable for CAS. The median age of the study population
was 64 years (IQR, 60 to 72 years). Fifty-nine percent of
the cases were asymptomatic, and 41% were symptomatic.
CE-MRA was performed a median of 8 days (IQR, 1 to 16
days) before DSA. Indications for CAS included high sur-
gical risk due to severe comorbidities in 28 (44%), hostile
neck (previous CEA, radical neck dissection, radiation,
permanent tracheostomy) in 15 (23%), high or low primary
or concomitant lesion (lesion above C2 or below the clav-
icle) in 12 (19%), and contralateral ICA occlusion in 9
(14%). Fifty-three patients (88%) underwent CAS with the
Abbott Accunet filter, five (8%) with FilterWire EZ system,
and two (4%) with Angioguard filter. Abbott Acculink
carotid stents (Abbott Vascular, Santa Clara, Calif) were
used in 50 procedures (83%), Carotid Wallstents (Boston
Scientific Corp, Natick, Mass) in six (10%), and PRECISE
carotid stents in 4 (7%).
Technical success was achieved in all 60 cases (100%)
deemed suitable for CAS from CE-MRA findings, and
results were satisfactory (residual stenosis, 20%). In all
Table. Accuracy of contrast-enhanced magnetic resonance
disease, and device sizes before carotid artery stenting usin
(n  64)*
Variable No.
Sensitivity, %
(95% CI) No.
Severe ICA stenosis (80%-99%) 46 87 (75-95) 11
CAS suitability 60 100 (94-100) 4
Aortic arch type (I vs II/III) 39 87 (73-95) 19
Bovine aortic arch configuration 26 100 (87-100) 37
Aortic arch imaging angle (45°-60°) 52 100 (93-100) 11
Tortuosity (moderate to severe)
ICA 14 93 (68-99) 49
CCA 3 75 (19-99) 60
Carotid plaque ulceration 12 75 (47-93) 46
ICA string sign 1 100 (25-100) 62
Stent
Diameter (6-8 mm vs 7-10 mm) 26 96 (81-100) 25
Length (0 mm) 25 68 (50-82) 22
EPD (diameter 4.5 mm) 10 83 (52-98) 46
CI, Confidence interval; PPV, positive predictive value; NPV, negative pred
CCA, common carotid artery; EPD, embolic protection device.
*Accuracy parameters and exact confidence intervals were computed with ainstances in which CAS was not considered suitable byCE-MRA and DSA, the procedure was not attempted. In
this series, no strokes occurred during or after CAS. One
patient died at home 7 days after uneventful CAS, presum-
ably from a myocardial infarction. Thus, the overall 30-day
stroke/death rate was 1.6%.
Quality analysis of CE-MRA images allowed examina-
tion either without artifacts (92%) or with artifacts (8%)
that did not hinder interpretation. No CE-MRA studies
were considered uninterpretable. The accuracy parameters
of vessel-based evaluation with CE-MRA using DSA as the
reference standard are summarized in the Table. Only in
three instances was signal void found on CE-MRA, and this
was considered to represent 70% stenosis.
Quantitative analysis of the degree of carotid stenosis
using CE-MRA and DSA revealed significant correlation
(Spearman   0.76; 95% CI, 0.63 to 0.85; P  .001; Fig
1). CE-MRA had 85% sensitivity (95% CI, 72% to 93%) to
detect severe carotid stenosis and 100% specificity (95% CI,
69% to 100%), according to ROC curve analysis with an
area-under-the-curve value of 0.92 (95% CI, 0.83 to 0.98).
Bland-Altman analysis revealed that CE-MRA measured a
lower percentage of carotid stenosis (bias, 4.4%; limits of
agreement,  22% to 13%; Fig 2). None of the CE-MRA
studies resulted in the degree of stenosis being overesti-
mated, whereas underestimation occurred in eight lesions
that involved a stenosis 80% by DSA.
CE-MRA had 100% sensitivity and 100% specificity of
to determine CAS suitability and a bovine configuration of
the aortic arch. The sensitivity and specificity of CE-MRA
were, respectively, 93% and 100% to determinemoderate to
severe ICA tortuosity, 75% and 100% for CCA tortuosity,
87% and 100% to estimate the type of aortic arch (type I vs
types II and III), and 75% and 98% to detect ulcerated
plaques. Correlation was excellent between CE-MRA and
iography to detect aortic arch and carotid morphology,
ital subtraction angiography as reference standard
pecificity, %
(95% CI) No. PPV, % (95% CI) No. NPV, % (95% CI)
0 (72-100) 46 100 (100-100) 11 71 (36-83)
0 (40-100) 60 100 (94-100) 4 100 (40-100)
0 (82-100) 39 100 (91-100) 19 76 (55-91)
0 (91-100) 26 100 (87-100) 37 100 (91-100)
2 (62-99) 52 98 (90-100) 11 100 (72-100)
0 (93-100) 14 100 (77-100) 49 98 (88-100)
0 (94-100) 3 100 (29-100) 1 98 (91-110)
8 (89-100) 12 92 (64-99) 46 92 (81-98)
0 (94-100) 1 100 (25-100) 62 100 (94-100)
6 (80-99) 26 96 (81-100) 25 96 (80-99)
6 (78-100) 25 96 (80-99) 22 64 (46-80)
0 (92-100) 10 100 (69-100) 2 96 (86-99)
value; CAS, carotid angioplasty and stenting; ICA, internal carotid artery;
ial proportion for one-way tables using the F distribution method.ang
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0.92; 95% CI, 0.86 to 0.95; P  .001), and lesion length
(Spearman   0.87; 95% CI, 0.77 to 0.92; P  .001) As
determined by vessel size measurements, the accuracy of
CE MRA to predict stent and embolic protection device
(EPD) sizes was 90% (Table).
The accuracy of CE-MRA to predict the optimal DSA
working projection of the aortic arch (ie, the degree of left
anterior oblique angulation) was 100%. The operative tech-
nique for CAS was altered because of the findings of
preoperative CE-MRA in 22 procedures (38%). The most
Fig 1. Scatter plots of the percentage (%) of carotid stenosis using
North American Symptomatic Carotid Endarterectomy criteria for
contrast-enhanced magnetic resonance angiography (CE-MRA)
vs digital subtraction angiography (DSA) revealed significant cor-
relation (Spearman   0.76; 95% confidence interval, 0.63 to
0.85; P  .001). The dashed lines indicate 95% confidence limits;
the solid line is the line of equality.
Fig 2. Bland-Altman plots reveal good agreement between mea-
surement methods even though contrast-enhanced magnetic res-
onance angiography (CE-MRA) measured a lower percentage of
carotid stenosis (dashed lines indicate 95% confidence limits; solid
line, bias) than digital subtraction angiography (DSA).frequent change was the use of the telescoping technique in11 CAS procedures (18%). This technique, in which the
sheath or guiding catheter are advanced over a hydrophilic
guidewire and a diagnostic catheter into the CCA,19 was
primarily used when CE-MRA and DSA revealed that the
target lesion was located in the distal CCA (n  6), the
external carotid artery was occluded (n  2), or for severe
arch tortuosity (types II and III; n  3). The use of
different types of stents based on CE-MRA findings oc-
curred in seven CAS procedures (11%), and the use of
different guiding or diagnostic catheters in six (9%). In five
patients (8%), CE-MRA revealed proximal common ca-
rotid (n  4) and innominate (n  1) lesions that were
verified with DSA and required proximal balloon angio-
plasty and stent placement. Four patients (6%) were not
treated with CAS because of unfavorable anatomy identi-
fied on CE-MRA and confirmed with DSA, including
prohibitive ICA tortuosity (n 1) that precluded the use of
an EPD, long string sign of the ICA (n 2), and concom-
itant intracranial disease (n  1).
DISCUSSION
The results of our study indicate that although CE-
MRA may not be as accurate as DSA to determine the
degree of carotid stenosis, it does provide very accurate
information about aortic arch and carotid morphology that
may facilitate and alter the procedural protocol and tech-
nique for CAS. Moreover, certain anatomic contraindica-
tions for CAS may be detected with CE-MRA, obviating
the need for DSA. Certain procedural details, such as
imaging angles, vessel size measurements, and stent and
EPD size, which may facilitate safe and expeditious CAS,
can be accurately predicted preoperatively with CE-MRA.
CE-MRA, CTA, and DUI are noninvasive methods
that have been evaluated as possible alternatives to DSA,
which is still considered the gold standard, to determine the
degree of carotid stenosis. Because of the definite risk of
local and systemic complications associated with carotid
DSA, many surgeons proceed with CEA with the sole
evaluation provided by DUI. CE-MRA has, however, often
been used to corroborate the degree of carotid stenosis
determined with DUI before CEA. Overall, most observa-
tional studies evaluating the utility of CE-MRA to assess
the degree of carotid stenosis have consistently revealed a
strong correlation with DSA as the reference standard,
although an occasional tendency toward overestimation
has been reported with CE-MRA.2-6,26 Of interest, no
overestimations of ICA stenosis were noted on CE-MRA in
our series; conversely, 7 of 53 severe (80%) stenoses were
underestimated.
Previous observational studies reporting overestima-
tions have included a wide range of ICA stenosis, with a
significant number of lesions with mild (50%) stenosis.2-6
The absence of overestimations in this study may be ex-
plained by the preferential inclusion of patients with severe
(80% to 99%) carotid stenosis (53/64 lesions [83%]).
Moreover, the use of ideal DSA imaging angles and projec-
tions predicted with CE-MRA instead of the conventional
two-view DSA and more conservative estimation of the
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dency for overestimation, may also account for the lack of
overestimations.
Underestimations of the degree of carotid stenosis with
CE-MRA, on the other hand, probably occurred because of
the presence of a signal void in all these lesions, which is
usually assumed by most neuroradiologists to represent a
70% stenosis according to previous studies.22,27 In our
data set, the degree of stenosis was entered arbitrarily as
70%when a signal void was observed; such carotid stenoses,
however, proved to be 80% with DSA in all cases.
CE-MRA has been frequently used to corroborate the
degree of carotid stenosis determined with DUI before
CEA, but to our knowledge, its specific utility in planning
CAS has not been reported. Because of the greater number
of projections available and higher spatial resolution that
allows routine evaluation from the aortic arch to the circle
of Willis, 3D CE-MRA has become our diagnostic imaging
modality of choice to evaluate patients before CAS. Com-
pared with previous pulse sequences to performMRA, such
as time-of-flight angiography, CE-MRA provides higher
image resolution, larger imaging fields, nearly complete
absence of motion and flow-related artifacts, shorter acqui-
sition times, and enhanced postprocessing and subtraction
algorithms that can depict aortic arch and carotid morphol-
ogy in great detail.28
Although CTA has been used to assess patients before
CAS,29 the use of ionizing radiation and potentially neph-
rotoxic iodinated contrast agents make it less attractive in
routine clinical practice. Moreover, because CAS may be
required urgently, particularly in symptomatic patients,
avoiding a second large dose of iodinated contrast material
within a short time span may be desirable.
Obviously, CTA should be the primary assessment in
patients with pacemakers, implants, and metallic stents.
Octogenarians and patients with heavily calcified plaques
may also be preferentially evaluated with CTA because it
allows enhanced visualization of vessel walls and plaques.
Because recent reports have revealed that gadolinium com-
pounds have been linked to the development of nephro-
genic systemic fibrosis in patients with renal insufficiency,
the use of gadolinium-based contrast agents in this patient
population is not currently defined.30 Of note, no specific
instances of nephrogenic systemic fibrosis have been asso-
ciated with the use of gadoteridol (ProHance, Bracco Di-
agnostics, Princeton,NJ), the contrast agent used for CE-
MRA in our series.
The safety and efficacy of CAS are primarily related to
patient selection, materials used, and operator experience.
Although both medical and anatomic factors may influence
the outcome of any carotid intervention, aortic arch and
carotid morphology are of utmost importance in patient
selection. In our study, CE-MRA had high diagnostic
accuracy in the evaluation of the type of aortic arch and
carotid tortuosity, the main limiting anatomic factors for
CAS.
The preoperative noninvasive identification of the type
of aortic arch and associated carotid tortuosity resulted in asubstantial change in our CAS technique in 38% of the
procedures. The use of the telescoping technique for ad-
vancing a sheath or guiding catheter into the distal CCA
and the selection of a different diagnostic catheter or guide-
wire were frequently determined preoperatively in patients
with type II and III aortic arches or carotid tortuosity, or
both, on the basis of the CE-MRA findings.
These procedural changes certainly resulted in the
avoidance of excessive catheter and wire manipulations in
the aortic arch and the CCAs. As demonstrated byHammer
et al,31 cerebral embolization may primarily originate from
the aortic arch, because embolic lesions are frequently
found outside the vascular territory of the target ICA. One
patient in our series was not treated with CAS because of
severe ICA tortuosity noted on CE-MRA. Therefore, our
data show that preoperative decisions can be based on
aortic arch and carotid morphology determined with CE-
MRA, avoiding patients with difficult anatomy and mini-
mizing catheter manipulations. Although all CAS proce-
dures in the current series were supervised by an
experienced interventionalist who had performed 100
CAS procedures, the primary operators of most of the cases
were vascular surgery fellows with no prior training in
carotid interventions. CE-MRA findings allowed accurate
planning of most of the CAS procedures by the trainees
with the staff vascular surgeon. In this regard, preoperative
carotid and arch CE-MRA could potentially contribute to
accelerate the learning curve for CAS, particularly in aca-
demic centers.
In our series, all CAS procedures were performed with
distal filter protection devices because these were the only
EPDs commercially available in the United States during
the study period. CE-MRA was highly accurate in deter-
mining the ICA diameter at the level of the potential EPD
deployment location, which resulted in a very accurate
prediction of the size of filter to be used. Moreover, ICA
tortuosity was also successfully assessed with CE-MRA for
potential difficulties in advancing an EPD. As noted, one
patient did not undergo CAS owing to prohibitive tortu-
osity of the proximal ICA that prevented safe placement of
any filter EPD. As new EPDs are introduced, particularly
occlusive systems with reversal of flow, the importance of
preoperative evaluation of collateral intracranial circulation
and carotid tortuosity with CE-MRA may be essential to
identify patients that may not tolerate CAS with temporary
complete ICA occlusion.
The CE-MRA findings resulted in a different type of
stent being used for CAS in seven patients (8%). Five were
symptomatic and had evidence of deep carotid plaque
ulcerations with high-grade stenosis. Two of these patients
underwent plaque composition analysis with intravascular
ultrasound imaging that confirmed large areas of necrotic
core with ruptured overlying thin fibrous cap. Because of
the potential increased risk of cerebral embolic events
among patients with carotid stenosis and ulcerated
plaques,32 closed-cell stents were used and postdilatation
was avoided to prevent the potential squeezing of plaque
material through the interstices of the stent. Conversely,
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underwent CAS with more flexible open-cell nitinol stents
that may accommodate better to tortuous vessels. CE-
MRA also accurately predicted stent size required for most
lesions based on lesion length and vessel diameter measure-
ments, which may be helpful in materials selection, partic-
ularly in settings with limited resources.
CONCLUSION
Our results show that CE-MRA is an effective preop-
erative imaging study in planning CAS because it provides
complete and accurate anatomic assessment from the aortic
arch to the intracranial circulation that may be particularly
useful during the early experience with CAS. Moreover,
procedural details such as optimal working projections and
imaging views, vessel size, and EPD and stent configura-
tions can be accurately predicted with CE-MRA. This may
result in shorter operative and fluoroscopy times and fewer
catheter and wire manipulations that may improve techni-
cal success and outcomes. Because most patients in this
study were men, our results should be interpreted with
caution in relation to women; indeed, the accuracy of
CE-MRA in planning CAS for women remains to be deter-
mined.
Finally, future developments such as the introduction
of newer contrast agents that may enhance signal intensity
and further refinements in high-spatial-resolution MRI to
evaluate plaque morphology and composition will certainly
make CE-MRA and MRI of the carotid plaque and brain
the technique of choice for the evaluation of patients before
CAS because most diagnostic information will be obtain-
able in a single comprehensive noninvasive imaging study.
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Dr William Jordan (Birmingham, Ala). First, I want to
congratulate Dr Timaran and his colleagues with his presentation
of this important treatment algorithm for carotid artery stenting.
In their series, he has demonstrated the utility of using additional
imaging of contrast-enhanced MRA to direct the planning of the
procedures specifically related to the aortic arch morphology, the
location of the stenosis, and the course of the distal carotid artery.
The proximal and distal arterial anatomy is not well imaged with
duplex ultrasound, thus making the adjunctive step of MRA a
helpful one to discover some anatomic limitations that might make
carotid stenting difficult.
The authors presented a very respectable clinical series of 60
patients, with only one death and no strokes. The stroke rate clearly
represents fine work that rivals some of the best reports in the
literature and clearly exceeds some of the early reports of 9% stroke
rates in the mid-90s. Currently, stroke rates are reported in the 3%
to 6% range, with the most scientifically valid randomized clinical
trials of EVA 3S and SPACE reporting rates of 6%, which brings to
light the first question. You had no strokes in your series, and one
presumed cardiac death. Can you provide us with a glimpse of your
carotid experience? This report represents two thirds of your total
cases. Did you do 30 cases first and then embark on MRA to assist
in case planning? Specifically, how many cases did you accomplish
prior to the series to reach the rate of no strokes?
When we look at our series from UAB in the 90s, we found
our learning curve to be almost 300 patients before the stroke rate
plunged from 9% to 3%. Some experts have suggested a learning
curve of 50 cases before one can be considered an experienced
carotid interventionalist. My personal experience, which suggests
learning from other nonsurgical “experts,” would place the learn-
ing curve well below the 50 cases that some have suggested or even
30 cases in some of the randomized protocols. I would appreciate
your comment on that principle of learning curve.
Second, I suspect many carotid interventionalists would sug-
gest the MRA is not required once you gained that initial experi-
ence. That is, an arteriogram will define the anatomic limitations
that would direct you to what catheter guide to use to cannulate
the vessel of interest. Additionally, the duplex scan should define
the location of stenosis, whether it is proximal or distal to the
external origin, and the initial angiogram can define the distal and
the proximal morphology to determine the best protection device.
Said more plainly, can’t you simply figure this out when you get
there rather than spending a few thousand dollars on a MRA prior
to the procedure?
Finally, I suspect you are using thisMRA to aid in the planning
process during your learning curve. This tool can help you decide
whether to take this patient to the next step of an angiogram and
stenting; therefore, theMRAwould be a nice planning tool to limit
the length or slope of your learning curve, particularly if you can
limit all strokes by avoiding complex anatomy as you have done in
this series. So, was the additional anatomic information reallyWhat about those patients that have a pacemaker or defibril-
lator? You know, those are being implanted almost as fast as carotid
stents these days. It seems that CT angio could provide the same
information and, actually, why not simply a time-of-flightMR scan
or a noncontrast CT scan? We can get lots of information this way.
Once again, let me congratulate you on your presentation and
the elegant statistical analysis that your manuscript accomplishes
on using this mechanism, but let me remind the rest of here today
that we as vascular surgeons remain the single discpline that can
offer both modalities of carotid surgery and stenting for a more
balanced approach of treating carotid disease. Thank you for
providing me a copy of the manuscript in a timely fashion well
before the meeting and for the privilege of the floor to discuss this
paper.
Dr Carlos Timaran: I was fortunate to perform a fair amount
of carotid stenting cases during my fellowship training prior to
joining UT Southwestern. I did my fellowship with Drs Ohki and
Veith at Montefiore Medical Center, and I was probably able to
perform about 50 carotid stenting cases as the primary operator
and another 50 or 60 cases as the assistant. Obviously, training and
experience give you some advantage, but I still believe you have to
plan these cases thoroughly because you never know what you are
going to encounter anatomically.
Of note, it is curious that I only began to use CE-MRA for
planning carotid stenting when I joinedUT Southwestern, primar-
ily because the patients that were referred for carotid interventions
already hadMRAs, which were usually of excellent quality. Clearly,
I was really pleased to see such MRA images. I was also able to do
all kinds of 3D reconstructions and manipulations of the images
using software, which prompted me to obtain CE-MRAs in every-
body considered for carotid stenting. Indeed, we currently do it for
almost everybody, except for those patients that have contraindi-
cations for MRI, including patients with pacemakers or defibrilla-
tors. Again, we try to get it in every patient, and despite our
increasing experience, we have not changed our practice.
Initially, we did it primarily because we had limited resources,
so CE-MRA allowed us to know if we needed to get extra materials
that we did not have in our shelves. Currently, we have almost
everything that is available for carotid stenting, but we still obtain
CE-MRA for different reasons. I think it is very important, partic-
ularly in teaching institutions, to go over these cases in detail prior
to the actual procedures with trainees because this may result in a
more expeditious procedure with decreased catheter and wire
manipulation of the aortic arch and the carotid arteries.
I think that if you get CE-MRA prior to carotid stenting with
excellent imaging, the learning curve may actually be shortened
because you do not have to do as many cases to learn different
alternatives. In fact, MRAs can certainly allow you to plan these
procedures more effectively. Obviously, carotid duplex gives you a
lot of information, but I prefer to see the images and do the 3D
reconstructions myself. Moreover, if you have a symptomatic pa-
tient, you are going to have to image the brain anyway, and
CE-MRA does not addmuch time or effort to a regular brainMRI.
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recent studies have shown that plaque composition can actually
be assessed with carotid coils. Thus, I think MRI is going to be
probably the tool of choice to evaluate carotid stenosis because
brain MRI, aortic arch and carotid MRA, and plaque composi-
tion will all be obtained in one setting. For patients with
rience and the types of protection devices available. In addition,contradictions for MRI, CTA is the best option as well as for
patients with heavy calcification and octogenarians. For the
latter, CTA is particularly important because it is imperative not
only to image the arch but also to assess the vessel wall as plaque
at this level can be the source of emboli during carotid stenting
in elderly patients.INVITED COMMENTARYChristopher J. Kwolek, MD, Boston, Mass
Dr Timaran and his colleagues have provided us with a timely
article discussing the potential use of magnetic resonance angiog-
raphy (MRA) in the preprocedural evaluation of patients undergo-
ing carotid angioplasty and stenting (CAS). This has become more
relevant given the recent publication of several trials which call into
question the efficacy of CAS compared with CEA for stroke
prevention. Discussion of these papers has once again brought out
the importance of careful patient selection, appropriate physician
training and experience, along with careful preprocedural planning
to minimize the risk of complications associated with CAS.
MRA may prove useful in identifying individual anatomic
factors such as the presence of ulcerated plaque, arch type, and
severe tortuosity. However, suitability for stenting is based not
only on anatomic factors, but also the individual physician’s expe-some institutions may prefer computed tomography angiograms
(CTA) as a more readily available or easier to interpret form of
noninvasive arterial imaging.
The current study is also limited in its generalized applica-
bility given the fact that only one woman and no patients over
the age of 80 were included in the evaluation. It is now well
recognized that octogenarians comprise a high risk subset of
patients undergoing CAS.
Future studies will hopefully elucidate which patients will
benefit most from preprocedural MR angiogram. In addition, it
will be important to justify the additional cost associated with this
procedure, since many centers report excellent results without
using MRA. Perhaps, it will be most useful for operators early in
their learning curve or in certain high risk groups of patients who
may have more complex anatomy such as those over the age of 80.
